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Abstract
Background: Newcastle disease (ND) is one of the most contagious and devastating diseases to poultry in the
world. The causative agents are virulent strains of Newcastle disease virus (NDV), which belong to the genus
Avulavirus, sub-family Paramyxoviridae, family Paramyxovirinae. Knowing the genomic and antigenic characteristics
of virulent NDVs might contribute to ND control in China.
Results: The results showed that all of the virulent strains belonged sub-genotype VIId shared the same cleavage
site 112RRQKR/F117 in the fusion protein. At least 69 % (38 of 55) of the NDV strains possessed E347K variation in the
hemagglutinin-neuraminidase protein. The cross-neutralization tests confirmed that the strains harboring 347 K
showed lower antigenic relatedness with LaSota. Furthermore, the immune-challenge experiment indicated that
LaSota could not provide complete protection against infection with the E347K variant NDVs as the vaccinated
birds were still able to be infected and shed virulent challenge viruses.
Conclusions: Currently, sub-genotype VIId NDVs are the prevalent virulent strains circulating among vaccinated
chicken flocks in Eastern China. Our findings indicated that the E347K variation in HN gene would expand the
antigenic difference with LaSota, which may be responsible for the increasing isolation rate of these strains from
vaccinated chickens.
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Background
Newcastle disease (ND) is one of the most contagious
and devastating diseases to poultry in the world [1].
The causative agents are virulent strains of Newcastle
disease virus (NDV), which belong to the genus Avula-
virus, sub-family Paramyxoviridae, family Paramyxovir-
inae [2, 3]. The viral RNA genome is approximately
15 kb in length and encodes six major virus proteins:
the nucleocapsid protein (NP), phosphoprotein (P), matrix
protein (M), fusion protein (F), hemagglutinin–neuramin-
idase (HN) and large polymerase protein (L). In addition,
the HN protein is an important multifunctional surface
glycoprotein that consists of a cytoplasmic domain, a
transmembrane region, a stalk region and a globular
head, in which the receptor–binding site, the site re-
sponsible for neuraminidase activity and all of the anti-
genic sites reside [4]. It has been confirmed that there
are seven overlapping antigenic sites in the HN protein,
whereas residues 345 to 353 constitute the only linear
epitope identified in the HN gene, which is susceptible
to immune pressure to generate antigenic variation [5].
Researchers have recently confirmed that the variation
in the linear epitope in the HN protein would intensify
the antigenic difference [6]. Previously, seven neutraliz-
ing epitopes positioned at residues 72, 74, 75, 78, 79,
157 to 171, and 343 of the F protein have been
identified.
The strains of NDV can be divided into two distinct
clades: class I and class II, and based on the older classi-
fication system, both clades could be divided into 9 ge-
notypes, and the class II clade can be divided into fifteen
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genotypes when based on the new classification system,
while the class I clade can be divided into three sub-
genotypes. To date, a strict vaccination policy has been
implemented in China and the vaccine strain LaSota
which belonged to genotype II has been widely used in
China for over 40 years. However, infections of genotype
VIId NDVs have still frequently occurred in China and
other Asian countries [7–13]. Meanwhile, there are also
some virulent genotypes (VIb, IX) circulating among
avian species in China [14, 15].
To elucidate the circulation of virulent NDVs among
chickens in Eastern China, 55 virulent NDVs isolated
from chicken flocks, including broilers and layers, from
2011 to 2013 were phylogenetically characterized.
Results
Isolation and identification of NDVs from clinical samples
Fifty-five NDVs from clinical samples of different chicken
flocks in Eastern China were isolated from 2011 to 2013,
identified and plaque-purified, and the details of the NDV
isolates are shown in Table 1.
Phylogenetic analysis
The phylogenetic analysis of the 55 NDVs based on the
whole F gene sequences showed that all strains were
clustered into sub-genotype VIId and they could be di-
vided into two separate groups, namely VIId1 (n = 3)
and VIId2 (n = 52), as previously described (Fig. 1) [7].
All of the strains isolated in 2012–2013 belonged to
VIId2, and only three of the twenty one strains isolated
in 2011 belonged to VIId1. All of the NDV isolates pos-
sessed the virulent F protein cleavage site motif
112RRQKR/F117. And over 70 % (39/55) of the isolates
shared K78R variation on the F gene.
Additionally, a phylogenetic analysis was also per-
formed based on the whole HN gene (Fig. 2). As deter-
mined from the phylogenetic tree based on the HN
gene, all of the NDV isolates showed a distribution simi-
lar to that obtained from the tree based on the F genes:
three in VIId1 and 52 in VIId2. Three residues, namely
T102, A118 and T443, were unique for VIId1, whereas
I102, E118 and M443 were characteristic residues of
VIId2. All of the NDV isolates shared 96.3 % to 100 %
nucleotide identity and 96.2 % to 99.8 % amino acid
identity. Only two isolates (JS-08-11-Ch and JS-10-11-
Ch) shared the E347G variation. More than 42.8 % of
the isolates in 2011 (9/21) exhibited the E347K variation
in HN, whereas 81.5 % (22 of 27) of those isolated in
2012 possessed this variation. The latter percentage is
nearly two-fold higher than that found in 2011, and
100 % (7 of 7) of the strains isolated in 2013 possessed
this variation. In addition, the layer-origin stains isolated
in 2011, 2012 and 2013 shared 67 % (6/9), 75 % (6/8)
and 100 % (3/3) of the E347K variation in the HN gene,
respectively. Furthermore, we found that all of the
strains harboring 347 K on HN also shared a G362A
mutation. However, the role of this mutation has not
been well elucidated. The 13 cysteine residues were con-
served as described previously, and with the exception of
the loss of a glycosylation site at 508 of JS-02-11, all of
the other NDVs possessed six well-identified glycosyla-
tion sites.
Pathogenicity tests
As is shown in Table 2, all the ten isolates were highly
virulent, which were consistent with the tyipical virulent
motif 112RRQKRF117 at the F cleavage sites.
Cross hemagglutination inhibition (HI) test and virus
neutralization test
The HI titers of the anti-LaSota serum for the ten iso-
lates were 4-8-fold lower than that for the homologous
strain LaSota, displaying the significance of the antigenic
difference between the NDV isolates and the vaccine
strain LaSota. As determined from the cross HI test, the
R values between the predominant strains and LaSota
were all lower than 0.5, indicating the existence of a sig-
nificant antigenic difference between the strains. Mean-
while the R values between the E347K-variant strains
and LaSota were lower than that found for the 347E/G
strains, which indicate that the E/G347K variation would
expand the antigenic difference with the vaccine strain.
And the significant antigenic difference was also con-
firmed by the R value obtained from cross-neutralization
test between LaSota and the predominant strains
(Table 3).
Test of the protective efficacy of the LaSota strain against
the variant strains
As is shown in Table 4, none of the birds vaccinated
with the LaSota vaccine showed clinical signs post chal-
lenge with JS-22-11-Ch or JS-14-12-Ch. In contrast,
100 % of the unvaccinated birds challenged with JS-22-
11-Ch or JS-14-12-Ch died within five days post chal-
lenge. All of the unchallenged birds remained normal
throughout the experiment.
As is shown in Table 5, tracheal and cloacal swabs
were collected from the birds at days 3, 5, and 7 post
challenge and subjected to virus isolation tests. The virus
isolation rate from the tracheal swabs was 100 % (5/5) at
day 3 post challenge in both the control-JS22 and
control-JS14 groups, whereas the isolation rates for the
La-JS22 and La-JS14 groups were 70 % (7/10) and 100 %
(10/10), respectively. And the virus isolation rate from
the tracheal swabs was 50 % (5/10) and 70 % (7/10) at
day 5 post challenge in La-JS22 and La-JS14 groups,
whereas the isolation rates at day 7 post challenge were
10 % (1/10) and 30 % (3/10), respectively.
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Discussion
The genotype VII NDVs have become the most preva-
lent strains in China since the 1990s, and the sub-
genotype VIId NDVs are mainly responsible for the
present ND epizootic in China [7, 13, 16]. In this study,
virulent NDVs from the vaccinated chicken flocks were
characterized as sub-genotype VIId and could be clus-
tered into sub-genotype VIId1 and VIId2 based on the
phylogenetic trees based on both F and HN genes [7].
T102, A118, and T443 of the HN gene were unique resi-
due substitutions found in the VIId1 NDVs, and I102,
E118, and M443 of the HN gene were characteristic resi-
dues of the VIId2 NDVs. In this study, we found that
sub-genotype VIId2 remains the predominant genotype
VII NDVs from 2011 to 2013, and all of the NDVs iso-
lated from 2012 to 2013 were located in this clade.
The HN protein of NDV plays an important role in
immune protection against virus infection, and the vari-
ation of the antigenic epitope would expand the anti-
genic difference. And analysis of the role of site 347 in
antigenicity has confirmed that the E347K variation
would intensify the antigenic difference and may in-
crease the risk of vaccine breakdown [17, 18]. The isola-
tion rate of strains with the E347K variation is increasing
yearly, as previous reported. More than 36 % of the virus
strains (20/55) were isolated in commercial layer flocks,
which have resulted in losses in egg production. Cho et
al. [18] found that the Korean variation strains have also
caused losses in egg production. Moreover, more than
75 % (15/20) of the NDV strains isolated from layer
flocks were the E347K-variation strains. The high isola-
tion rate indicates that the E347K-variation strains can
Table 1 NDVs characterized in this study
NDV isolates Year of
isolation
Host F gene 345–353
Residues of HN
HN gene NDV isolates Year of
isolation
Host F gene 345–353
Residues of HN
HN gene
JS-01-11-Ch 2011 Broiler JQ013855 PDEQDYQIR JQ013835 JS-09-12-Ch 2012 Layer KJ184579 PDKQDYQIR KJ184625
JS-03-11-Ch 2011 Broiler JQ013857 PDEQDYQIR JQ013838 JS-10-12-Ch 2012 Layer KJ184580 PDKQDYQIR KJ184626
JS-04-11-Ch 2011 Layer JQ013858 PDEQDYQIR KJ184630 JS-11-12- Ch 2012 Layer KJ184581 PDKQDYQIR KJ184627
JS-05-11-Ch 2011 Layer JQ013859 PDEQDYQIR KJ184631 JS-12-12-Ch 2012 Broiler KJ184582 PDKQDYQIR KJ184601
JS-06-11-Ch 2011 Layer JQ013860 PDKQDYQIR JQ013839 JS-13-12-Ch 2012 Broiler KJ184583 PDKQDYQIR KJ184602
JS-07-11-Ch 2011 Broiler JQ013861 PDKQDYQIR KJ184632 JS-14-12-Ch 2012 Broiler KJ184584 PDKQDYQIR KJ184603
JS-08-11-Ch 2011 Broiler JQ013862 PDGQDYQIR KJ184633 AH-02-12-Ch 2012 Layer KJ184597 PDKQDYQIR KJ184616
JS-09-11-Ch 2011 Broiler JQ013863 PDEQDYQIR KJ184634 HeN-01-12-Ch 2012 Layer KJ184598 PDKQDYQIR KJ184617
JS-10-11-Ch 2011 Layer JQ013864 PDGQDYQIR JQ013840 SD-01-12-Ch 2012 Broiler KJ184594 PDKQDYQIR KJ184613
JS-11-11-Ch 2011 Layer JQ013865 PDKQDYQIR JQ013841 SD-02-12-Ch 2012 Broiler KJ184595 PDKQDYQIR KJ184614
JS-12-11-Ch 2011 Broiler JQ013866 PDEQDYQIR JQ013842 SD-03-12-Ch 2012 Broiler KJ184596 PDKQDYQIR KJ184615
JS-13-11-Ch 2011 Broiler JQ013867 PDEQDYQIR JQ013843 JS-16-12-Ch 2012 Broiler KJ184585 PDKQDYQIR KJ184604
JS-14-11-Ch 2011 Broiler JQ013868 PDKQDYQIR JQ013852 JS-17-12-Ch 2012 Broiler KJ184586 PDKQDYQIR KJ184605
JS-15-11-Ch 2011 Broiler JQ013869 PDEQDYQIR JQ013844 JS-18-12- Ch 2012 Broiler KJ184587 PDEQDYQIR KJ184606
JS-16-11-Ch 2011 Broiler JQ013870 PDKQDYQIR JQ013845 JS-19-12-Ch 2012 Broiler KJ184588 PDKQDYQIR KJ184607
JS-17-11-Ch 2011 Layer JQ013871 PDKQDYQIR JQ013846 JS-20-12-Ch 2012 Broiler KJ184589 PDKQDYQIR KJ184608
JS-19-11-Ch 2011 Layer JQ013873 PDKQDYQIR JQ013847 JS-21-12-Ch 2012 Broiler KJ184590 PDKQDYQIR KJ184609
JS-20-11-Ch 2011 Broiler JQ013874 PDEQDYQIR JQ013848 JS-22-12-Ch 2012 Broiler KJ184591 PDEQDYQIR KJ184610
JS-21-11-Ch 2011 Broiler JQ013875 PDEQDYQIR JQ013851 JS-23-12-Ch 2012 Broiler KJ184592 PDKQDYQIR KJ184611
SD-01-11-Ch 2011 Layer JQ013877 PDKQDYQIR JQ013850 JS-24-12-Ch 2012 Broiler KJ184593 PDKQDYQIR KJ184612
SD-02-11-Ch 2011 Layer JQ013878 PDKQDYQIR JQ013849 JS-21-13-Ch 2013 Layer KP064014 PDKQDYQIR KP064023
JS-02-12-Ch 2012 Layer KJ184599 PDKQDYQIR KJ184618 JS-22-13-Ch 2013 Broiler KP064015 PDKQDYQIR KP064024
JS-03-12-Ch 2012 Broiler KJ184600 PDEQDYQIR KJ184619 JS-23-13-Ch 2013 Broiler KP064016 PDKQDYQIR KP064025
JS-04-12-Ch 2012 Broiler KJ184574 PDEQDYQIR KJ184620 JS-24-13-Ch 2013 Layer KP064017 PDKQDYQIR KP064027
JS-05-12-Ch 2012 Broiler KJ184575 PDEQDYQIR KJ184621 JS-27-13-Ch 2013 Layer KP064018 PDKQDYQIR KP064021
JS-06-12-Ch 2012 Layer KJ184576 PDKQDYQIR KJ184622 JS-30-13-Ch 2013 Broiler KP064020 PDKQDYQIR KP064026
JS-07-12-Ch 2012 Layer KJ184577 PDKQDYQIR KJ184623 SD-25-13-Ch 2013 Broiler KP064019 PDKQDYQIR KP064022
JS-08-12-Ch 2012 Broiler KJ184578 PDKQDYQIR KJ184624
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Fig. 1 Phylogenetic tree of 55 sub-genotype VIId NDV strains based on the whole region of the F gene
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Fig. 2 Phylogenetic tree of 55 sub-genotype VIId NDV strains based on the complete HN gene
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infect chickens under immune pressure because the
layers were all well-vaccinated in China. Both site 347
and site 362 locate around the receptor-binding pocket,
and we found of E347K, G362A co-variant strains,
whereas Cho et al. also identified two strains with the
E347K and G362R co-variant ones. However, the role of
the co-variation remains unknown [6].
At present, LaSota is widely and frequently used to
prevent NDV infection in the poultry industries in
China; however, virulent NDV infections continue to
occur in the well-vaccinated chicken flocks [12, 19].
Moreover, both cross HI and cross-neutralization tests
were performed, and the R values of all of the strains
were lower than 0.5. However, the R values between the
E347K-variant strains and LaSota were lower than that
found for the 347E/G strains, which indicate that the
E347K variation would expand the antigenic difference
with the vaccine strain. Therefore, the results of the
cross-neutralization and cross HI experiments may also
be consistent with the higher isolation rate of the
E347K-variant strains, which demonstrated significant
antigenic differences between the vaccine strain and the
predominant variant strains should be responsible for
the outbreaks of ND in China.
In addition, the protection efficiency of LaSota against
the E347K variation strains in China is not well-
elucidated. In this study, the vaccinated SPF chickens
were fully protected against morbidity and mortality, but
virus shedding was not stopped. Our data suggest that
the LaSota inactivated vaccine cannot protect chickens
from virus shedding when infected with the variant
NDVs, and the variant strain challenged group showed
higher virus isoation rate which may be one of the rea-
sons for the circulation of sub-genotype VIId variation
strains in vaccinated chicken flocks.
In conclusion, our findings indicate that the sub-
genotype VIId NDVs with E347K variation in the HN
protein are predominant in eastern China and that this
variation would intensify the antigenic difference with
the vaccine strains. Moreover, the vaccine strain LaSota
has been used for more than 40 years and can hardly
protect chickens effectively from virus shedding when
infected with the circulation strains. Therefore, new
NDV vaccines closely related to the prevalent genotype
VIId viruses should be developed to control ND in
China.
Conclusions
Currently, sub-genotype VIId NDVs are the prevalent
virulent strains circulating among vaccinated chicken
flocks in Eastern China. Our findings indicate that the
E347K variation in HN protein would expand the anti-
genic difference with LaSota, which may be responsible
for the increasing isolation rate of these strains from
vaccinated chickens.
Methods
Virus isolation and antiserum preparation
Fifty-five virulent NDVs were isolated from 190 clinical
samples from different flocks in Eastern China from
2011 to 2013 under the permission of the flock owners.
All of the viruses were plaque-purified three times on
primary chicken embryo fibroblasts (CEF) and prolifer-
ated in 9-10-day-old specific-pathogen-free (SPF)
chicken embryos [20]. The virus stocks grown in allan-
toic fluids were stored at −70 °C until use.
SPF chickens (five in each group) were vaccinated with
inactivated, oil-emulsion derived from LaSota and the
strains listed in Table 2. The serum for the five birds
vaccinated with the same vaccine were pooled together
Table 2 Coefficients of antigenic similarity (R) between NDV
isolates and LaSota strain
Strains R valuec 345–353 Residues of HN
SD-01-11-Ch 0.04a 0.12b PDKQDYQIR
JS-07-11-Ch 0.12a 0.12b PDKQDYQIR
JS-14-12-Ch 0.06a 0.12b PDKQDYQIR
HeN-01-12-Ch 0.12a 0.12b PDKQDYQIR
JS-27-13-Ch 0.17a 0.25b PDKQDYQIR
JS-08-11-Ch 0.35a 0.35b PDGQDYQIR
JS-15-11-Ch 0.35a 0.5b PDEQDYQIR
JS-05-12-Ch 0.35a 0.35b PDEQDYQIR
JS-18-12-Ch 0.25a 0.35b PDEQDYQIR
JS-22-12-Ch 0.35a 0.35b PDEQDYQIR
aChicken embryo cross-neutralization test
bCross-hemagglutination inhibition test
c0.67 ≤ R ≤ 1.5, indicates no significant antigenic difference between the
two viruses
0.5 ≤ R ≤ 0.67 indicates a minor difference between the two viruses
R < 0.5 indicates a major difference between the two virus strains
Table 3 Pathogenicity tests of the isolates











aMDT =mean death time
bICPI = intracerebral pathogenicity index
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at three weeks post-vaccination and stored at −70 °C
until use.
All of the SPF chicken embryos and the SPF chickens
used in this study were bought from Beijing Merial Vital
Laboratory Technology Co., LTD.
Viral RNA purification, RT-PCR, and sequencing of the F
and HN genes
Virus preparation, viral RNA extraction and the initial
RT reaction were performed as described previously
[21]. Based on the published F and HN gene sequences
in the GenBank database, we designed two pairs of
primers (Table 6) for amplifying the F and HN genes of
the virulent NDV isolates. And we also designed a pair
of primers based one the same region of all NDV F
genes which could be used for NDV identification. PCR
products possessing the expected length were purified
and sequenced by Sangon (Shanghai, China).
Sequence analysis
Nucleotide sequence editing, analysis and prediction of
the amino acid sequences for both the F and HN pro-
teins and alignments were conducted using the Clustal
W multiple alignment method in the MegAlign program
of the Lasergene package (DNASTAR Inc., Madison,
WI, USA). Phylogenetic trees based on the F and HN
genes were constructed using the MEGA 5 program
(Version 5.2) with the maximum likelihood method al-
gorithm [22]. In addition to the 55 strains collected in
this study, 31 previously reported F and HN gene se-
quences representing different genotypes were included for
comparison, and the accession numbers of each of these
NDVs are shown in the phylogenetic trees [7, 16, 21].
Pathogenicity tests
The intracerebral pathogenicity index in 1-day-old chicks
and the mean death time in 9 to 11-day-old SPF chicken
embryos were determined for some of the isolates in this
study as Liu did previously [7].
Cross hemagglutination inhibition (HI) test and virus
neutralization test
To measure the antigenic difference between the vaccine
strain LaSota and the isolated strains, we selected ten
strains (One harboring 347G, four harboring 347E, and
five harboring 347 K) and performed cross HI and virus
neutralization test as describe by Cho and Li [8, 23].
Briefly, virus-serum mixtures were inoculated into the
allantoic cavity of 10-day-old SPF chicken embryos
0.2 mL per sample. At the same time, blank controls
and no-serum control samples were prepared by inocu-
lating with an equal volume of PBS or virus. Eight days
after incubation, the virus present in the chorioallantoic
sac was titrated by calculating the 50 % virus
neutralization endpoint. Virus neutralizing activity was
determined relative to the no-serum control. The anti-
genic relatedness of the predominant strains and LaSota
strain was expressed using the R value, as described by
Archetti and Horsfall [24]. The following formula was
used: R ¼ ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃr1  r2p , where r1 is the titer of strain A
with antiserum B divided by the titer of strain A with
antiserum A, and r2 is the titer of strain B with anti-
serum A divided by the titer of strain B with antiserum
B. A result of 0.67 ≤ R ≤ 1.5 indicates no significant anti-
genic difference between the two viruses, whereas 0.5 ≤
R ≤ 0.67 indicates a minor antigenic difference between






Strain Route NO. birds Clinical signs Mortality
La-JS22 6.3 ± 1.8 JS-01-11-Ch ED/IN 10 0/10 0 % (0/10)
La-JS14 6.3 ± 1.8 JS-14-12-Ch ED/IN 10 0/10 0 % (0/10)
Control-JS22 0 JS-01-11-Ch ED/IN 5 5/5 100 % (5/5)
Control –JS14 0 JS-14-12-Ch ED/IN 5 5/5 100 % (5/5)
La-PBS 6.3 ± 1.8 PBS ED/IN 5 0/10 0 % (0/5)
Control-PBS 0 PBS ED/IN 5 0/10 0 % (0/5)
aLa-JS22 and Control-JS22 = Challenge with 106 EID50 JS-22-11-Ch; La-JS14 and Control-JS14 = Challenge with 10
6 EID50 JS-14-12-Ch
Table 5 Frequency of isolation of challenge virus from SPF
chickens
Group Samples (positive/total)
Day 3 pc Day 5 pc Day 7 pc
OS CS OS CS OS CS
La-JS22 7/10 2/10 5/10 6/10 1/10 2/10
La-JS14 10/10 5/10 7/10 7/10 3/10 4/10
Control-SD 5/5 5/5 – – – –
Control-JS 5/5 5/5 – – – –
–the birds were all dead within the day 5pc
OS = oral swabs; CS = cloacal swabs
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the two viruses. An R value of R < 0.5 indicates a major
antigenic difference between the two virus strains.
Test of the protective efficacy of the LaSota strain against
the variant strains
To determine whether the vaccine strain LaSota with a
low antibody level can fully protect against the variant
strains, two strains, namely, JS-22-11-Ch (347E, 362G)
and JS-14-12-Ch (347 K, 362A), were selected, and a lo-
cally produced, inactivated, oil-emulsion vaccine derived
from the LaSota strain (109.3EID50) was used in this
study [25]. Twenty-five birds were immunized via the
intramuscular route with a single dose (0.1 ml) of the
LaSota vaccine. Fifteen birds were not vaccinated and
served as a control group. Three weeks post-vaccination,
20 vaccinated birds were chosen and divided into two
groups of 10. The birds in the La-JS22 group were chal-
lenged with 106.0 EID50/100 μl JS-22-11-Ch (n = 10) via
the eye drop and intranasal route (ED/IN route; 100 μl),
and those in the La-JS14 group were challenged with JS-
14-12-Ch (n = 10) via same (100 μl) route (ED/IN route).
The unvaccinated birds were also challenged with JS-22-
11-Ch (n = 5) or JS-14-12-Ch (n = 5) as described above
and were grouped in the Control-JS22 and Control-JS14
groups. Ten birds in the Control-La and Control-PBS
groups (five LaSota-vaccinated birds and five unvaccin-
ated birds) were challenged with the same volume
(100 μl) of PBS via the same route. All of the birds were
monitored daily for overt clinical signs (depression, re-
spiratory signs, diarrhea, etc.) and mortality. Tracheal
and cloacal swabs were collected from birds at days 3, 5,
and 7 post-challenge (pc) for virus isolation.
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